| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 05/22/2009 | CA2705508A1 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide |
| 05/21/2009 | US20090131531 Amide Compounds and their Use |
| 05/20/2009 | EP2059498A2 Treatment of cancer |
| 05/20/2009 | CN101434558A Salicylic acid-sphingoid base derivative and uses thereof |
| 05/20/2009 | CN101434557A Derivative of short chain 2-hydroxy carboxylic acid of ceramide |
| 05/19/2009 | US7534914 Substituted methyl aryl or heteroaryl amide compounds |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | US7534813 2-(4-substituted phenoxy)ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate orally coadministered with a decarboxylase inhibitor or a catechol O-methyltransferase inhibitor; improved bioavailability when administered in the colon; sustained release; sleep disorders; nervous system disorders |
| 05/19/2009 | US7534751 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners |
| 05/14/2009 | WO2009062082A2 Selective estrogen receptor modulator compositions and methods for treatment of disease |
| 05/14/2009 | WO2009061744A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/14/2009 | WO2009060882A1 Amide compound and bacterial disease control agent for agricultural and horticultural use |
| 05/14/2009 | CA2714808A1 Selective estrogen receptor modulator compositions and methods for treatment of disease |
| 05/14/2009 | CA2713394A1 Anti-inflammatory quinic acid derivatives for oral administration |
| 05/14/2009 | CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/13/2009 | EP2058297A1 Use of alkamides for masking an unpleasant flavor |
| 05/13/2009 | EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives |
| 05/13/2009 | CN100486957C Process for producing amine derivatives |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/07/2009 | WO2009057199A1 Retinoid prodrug compound |
| 05/07/2009 | WO2009057133A2 A process for the synthesis of 2-[2-[4-[(4-chlorophenyl)phenyl methyl]-1-piperazinyl] ethoxy acetic acid |
| 05/07/2009 | WO2009057130A2 An improved method for manufacturing footwear and footwear made according to said method |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | US20090118532 Process for the Synthesis of Mandipropamid and Derivatives Thereof |
| 05/07/2009 | US20090118257 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703684A1 Retinoid prodrug compound |
| 05/06/2009 | EP2054376A1 Process for preparing carboxamides by hydrolysis of carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN100484914C 1-carbamoylcycloalkylcarboxylic acid compounds, processes fro making and uses thereof |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2009053808A2 Histone deacetylase inhibitors |
| 04/30/2009 | WO2005113485A3 Stable nateglinide form b compositions |
| 04/30/2009 | US20090112004 Synthesis of quaternary salt compounds |
| 04/30/2009 | US20090111874 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | CA2703231A1 Histone deacetylase inhibitors |
| 04/29/2009 | EP2051958A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | EP1558565B1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN101421228A Preparation of chiral amides and amines |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN101417960A Method for preparing 1,1-cyclohexanediacetic acid mono amide |
| 04/29/2009 | CN100482639C N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/29/2009 | CN100482637C Compounds and compositions for delivering active agents |
| 04/29/2009 | CN100482626C Novel atisane compound and use thereof |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | CA2361716C Method of preparing alkylated salicylamides |
| 04/28/2009 | CA2339765C Compounds and compositions for delivering active agents |
| 04/23/2009 | WO2009050365A2 Method for preparing (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin, which can be used in therapeutics as an anticancer agent |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105319 Naphthalene-based inhibitors of anti-apoptotic proteins |
| 04/23/2009 | US20090105309 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 04/22/2009 | EP1285908B9 Substituted phenylpropionic acid derivatives |
| 04/22/2009 | CN101412673A Deltamethrin antigen and antibody, as well as use thereof |
| 04/21/2009 | US7521579 Process for the preparation of alpha hydroxycarboxylic acid amides |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/21/2009 | CA2338358C Compounds and compositions for delivering active agents |
| 04/16/2009 | DE202008016372U1 Vitamin enthaltende Zusammensetzung Vitamin-containing composition |
| 04/16/2009 | DE102007049039A1 Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung Process for the preparation of 8-hydrazino-8-aryl-Octanoylderivaten and their use |
| 04/15/2009 | EP2046734A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 04/15/2009 | EP2046725A2 Processes for the synthesis of o-desmethylvenlafaxine |
| 04/15/2009 | EP1567479B1 Fungicides |
| 04/14/2009 | US7518017 Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/09/2009 | WO2009043784A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 04/09/2009 | WO2009004141A3 Method for preparing enantiomerically enriched n-carboxyanhydride |
| 04/09/2009 | WO2008073623A3 Soluble epoxide hydrolase inhibitors |
| 04/09/2009 | WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/09/2009 | US20090093534 Mu opioid receptor ligands: methods of use and synthesis |
| 04/09/2009 | US20090093388 Novel acyl group-containing composition |
| 04/09/2009 | US20090091234 Room temperature molten salt and display element |
| 04/09/2009 | CA2700857A1 Hdac inhibitors |
| 04/09/2009 | CA2699625A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 04/08/2009 | EP2044006A1 Insecticidal compounds |
| 04/08/2009 | EP2044005A2 Prolyl hydroxylase inhibitors and methods of use |
| 04/08/2009 | EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 04/08/2009 | CN101404879A Process for producing lactamide compounds, new lactamide compounds and formulations containing lactamide compounds |
| 04/08/2009 | CN101402562A Novel benzophenone derivatives or salts thereof |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475776C Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514471 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 04/07/2009 | US7514425 Short-acting sedative hypnotic agents for anesthesia and sedation |
| 04/07/2009 | CA2362833C Phenylalaninol derivatives |
| 04/02/2009 | WO2008128207A9 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 04/02/2009 | WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 04/02/2009 | US20090085008 Cellulose compound composition and cellulose compound film |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
| 04/01/2009 | EP2041087A1 2 -oxybenzamide derivatives as parp inhibitors |
| 04/01/2009 | EP2041073A1 Cxcr2 inhibitors |
| 04/01/2009 | EP2041072A1 Cxcr2 antagonists |